Co-Diagnostics Inc (CODX)
1.15
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
1.15
0.00 (0.00%)
After-Hours: 20:00
Co-Diagnostics SG&A Expense (Quarterly): 5.921M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.921M |
September 30, 2023 | 5.052M |
June 30, 2023 | 5.447M |
March 31, 2023 | 4.720M |
December 31, 2022 | 6.580M |
September 30, 2022 | 5.512M |
June 30, 2022 | 3.941M |
March 31, 2022 | 5.574M |
December 31, 2021 | 5.321M |
September 30, 2021 | 7.173M |
June 30, 2021 | 8.322M |
March 31, 2021 | 4.133M |
December 31, 2020 | 5.633M |
September 30, 2020 | 3.002M |
June 30, 2020 | 2.581M |
March 31, 2020 | 1.728M |
Date | Value |
---|---|
December 31, 2019 | 1.280M |
September 30, 2019 | 1.323M |
June 30, 2019 | 1.060M |
March 31, 2019 | 0.8965M |
December 31, 2018 | 1.436M |
September 30, 2018 | 1.330M |
June 30, 2018 | 0.9926M |
March 31, 2018 | 0.9773M |
December 31, 2017 | 1.202M |
September 30, 2017 | 1.523M |
June 30, 2017 | 0.5071M |
March 31, 2017 | 0.919M |
December 31, 2016 | 0.2449M |
September 30, 2016 | 0.2123M |
June 30, 2016 | 0.2093M |
March 31, 2016 | 1.128M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.060M
Minimum
Jun 2019
8.322M
Maximum
Jun 2021
4.437M
Average
5.052M
Median
Sep 2023
SG&A Expense (Quarterly) Benchmarks
PAVmed Inc | 11.72M |
Perspective Therapeutics Inc | 1.694M |
Electromed Inc | 8.175M |
Xtant Medical Holdings Inc | 20.45M |
Asensus Surgical Inc | 7.773M |